Leaflet:information for the user
Glycilax adults 6.75 g rectal solution
glycerol
Read the entire leaflet carefully before starting to use this medicine, as it contains important information for you
Follow the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist exactly.
You should consult a doctor if it worsens or does not improve after 7 days of treatment.
Contents of the leaflet
5 Conservation of Glycilax adults
This medicine contains glycerol, a laxative that is administered rectally. The laxative effect is achieved by the ability of glycerol to soften the stool, which, together with a slight local irritating action, stimulates the movements of the intestine.
It is indicated for the local symptomatic relief of transient and occasional constipation in adults and adolescents from 12 years of age.
You should consult a doctor if it worsens or does not improve after 7 days of treatment.
Do not useGlycilax adults
Warnings and precautions
Consult your doctor or pharmacist before starting to use Glycilax adults.
Children and adolescents
This medicine is contraindicated in children under 12 years of age.
Other medicines andGlycilax adults
Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medicine.
Due to the type of medicine it is, its route of administration, this medicine does not affect the use of other medicines.
Use of Glycilax adultswith food and drinks
The intake of food and drinks does not affect the efficacy of this medicine.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Driving and using machines
The use of this medicine does not affect the ability to drive and/or use machines.
Follow the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist exactly. In case of doubt, ask your doctor or pharmacist.
The recommended dose is:
Adults and adolescents from 12 years of age: 1 package per day, when necessary, or as prescribed by the doctor.
This medicine is for rectal use only, do not ingest it.
Form of administration:
This medicine is administered rectally.
At the chosen time for administration, and once the cap that closes the end of the package in the form of a cannula is removed, place it in a vertical position with the tip upwards and press lightly so that a few drops of the medicine moisten the end in the form of a cannula, in order to facilitate its introduction into the rectum. Once introduced into the rectum, squeeze the package until it is completely empty and remove it gently without stopping pressing on its walls.
Repress the evacuation, keeping the buttocks tight, for as long as possible so that the medicine can exert its action perfectly.
Although there may be remains in the package after administration, the supply of the indicated dose is guaranteed. Each package contains a single dose of the product. It should be discarded after use.
If you notice resistance at the time of application, you should interrupt it, as it may be harmful and damaging, and consult a doctor.
Do not use the medicine for more than 7 consecutive days. If the symptoms do not improve, you should suspend treatment and go to the doctor.
Use in children
Do not administer to children under 12 years of age.
If you use more Glycilax adultsthan you should
It is unlikely that intoxication pictures will occur due to its use.
The abusive and prolonged use of this medicine can lead to an irritable colon syndrome (symptoms or discomfort such as alternation of constipation and diarrhea, intestinal spasms, bloating, nausea, and gases).
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicology Information Service, phone 91.562.04.20, indicating the medicine and the amount ingested.
If you have any other doubts about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone gets them.
During the period of use of glycerol by rectal route as a laxative, the following side effects have been observed, whose frequency has not been established with precision:
Reporting of side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish Medicines and Health Products Agency (AEMPS) website: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
It does not require special storage conditions.
Do not use this medicine after the expiration date that appears on the package after CAD. The expiration date is the last day of the month indicated.
Medicines should not be thrown away through the sewers or in the trash. Deposit the packages and medicines that you no longer need in the SIGRE Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packages and medicines that you no longer need. This way, you will help protect the environment.
Composition ofGlycilax adults
Appearance of the product and contents of the package
Glycilax adults is a transparent and yellowish rectal solution.
The medicine is presented in single-dose packages of 7.5 ml of polyethylene with a cannula-shaped end and a closing plug, which are packaged in boxes containing 4 or 12 single-dose packages.
Only some package sizes may be marketed.
Marketing authorization holderand manufacturer
Marketing authorization holder:
Laboratorios Cinfa, S.A.
Carretera Olaz-Chipi, 10. Polígono Industrial Areta
31620 Huarte (Navarra) – Spain
Manufacturer:
LAINCO, S.A.
Avda. Bizet, 8-12
08191 Rubí (Barcelona)
Spain
Date of the last revision of this leaflet:February 2025
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)
You can access detailed and updated information about this medicine by scanning the QR code included in the leaflet and packaging with your mobile phone (smartphone). You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/80818/P_80818.html
QR code to: https://cima.aemps.es/cima/dochtml/p/80818/P_80818.html
https://cima.aemps.es/cima/dochtml/p/80818/P_80818.html